Prostemics Co Ltd
KOSDAQ:203690
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
P
|
Prostemics Co Ltd
KOSDAQ:203690
|
58.3B KRW |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
412.7B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.6B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
186.2B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.6B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
70.6B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.8B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Prostemics Co Ltd
Glance View
PROSTEMICS Co., Ltd. engages in the provision of stem cell cosmetics and medicine. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-09-30.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Prostemics Co Ltd is 0.5%, which is above its 3-year median of -0.5%.
Over the last 3 years, Prostemics Co Ltd’s Gross Margin has decreased from 5.6% to 0.5%. During this period, it reached a low of -1.7% on Jun 30, 2024 and a high of 5.6% on Aug 30, 2022.
